scorecardresearch
Thursday, April 25, 2024
TopicPharma

Topic: Pharma

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Four killed, over 10 injured in explosion at pharma plant in Telangana

Explosion in reactor at pharmaceutical company in Sangareddy district triggered fire. Relief operations underway.

Govt move to review drug pricing mechanism triggers concern as pharma industry invited to join panel

Panel formed by Centre to review pricing framework for drugs & medical devices will have representatives from Indian Pharmaceutical Alliance & Indian Drug Manufacturers Association.

India denies nod to ‘1st-ever weekly insulin’ for diabetics, seeks more info from maker Novo Nordisk

Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

Special inspection drive by drug controllers in 20 states, 26 pharma companies show-caused

The Drug Controller General of India (DCGI) has carried out nationwide inspections following a spate of incidents where drugs imported from India were found to be substandard or spurious.

Meth manufacturing drugs worth Rs 390 cr seized in Mizoram, probe suggests trafficking to Myanmar

Assam Rifles and the Mizoram customs department seized 39,04,000 triprolidine and pseudoephedrine tablets which act as precursors in manufacturing of addictive crystal methamphetamine.

India-made ‘artificial tears’ linked to superbug outbreak in US. FDA restricts imports

Chennai-based Global Pharma's eye drops were linked to drug-resistant bacteria outbreak, which 'infected 55 & led to the death of one person'.

On Camera

BJP has a problem of plenty in Phase 2. It can only go down from that

BJP’s fate in the second phase of 2024 Lok Sabha election will be decided in Karnataka, Rajasthan, and Maharashtra, where it performed very well in 2019 but faces a stiff competition now.

Kotak Mahindra Bank shares drop 10% after RBI bans it from taking new customers via digital channels

The private lender's shares tumbled to be top Nifty 50 loser after India's central bank barred it from taking on new customers through online and mobile banking channels.

Rafale to Exercise Garuda, a look at Indo-French defence ties as Chief of Defence Staff visits France

Another addition to military cooperation has been the Strategic Space Dialogue, inaugurated in Paris in 2023. Last month, India participated as an observer to France’s AsterX.

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.